{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:26:54Z","timestamp":1793831214215,"version":"4.6.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:00:00Z","timestamp":1743120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:00:00Z","timestamp":1743120000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-95409-9","type":"journal-article","created":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T20:49:06Z","timestamp":1743194946000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Age at onset and clinical course of RBM20-mediated cardiomyopathy"],"prefix":"10.1038","volume":"15","author":[{"given":"Ramin","family":"Garmany","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Castrichini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Neves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveen L.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciorsti","family":"MacIntyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay W.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Ackerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Giudicessi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,28]]},"reference":[{"key":"95409_CR1","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.healun.2013.08.006","volume":"32","author":"LH Lund","year":"2013","unstructured":"Lund, L. H. et al. The Registry of the international society for heart and lung transplantation: Thirtieth official adult heart transplant report\u20132013; focus theme: age. J. Heart Lung Transpl. 32, 951\u2013964 (2013).","journal-title":"J. Heart Lung Transpl."},{"key":"95409_CR2","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/joim.12944","volume":"286","author":"D Reichart","year":"2019","unstructured":"Reichart, D., Magnussen, C., Zeller, T. & Blankenberg, S. Dilated cardiomyopathy: from epidemiologic to genetic phenotypes: A translational review of current literature. J. Intern. Med. 286, 362\u2013372 (2019).","journal-title":"J. Intern. Med."},{"key":"95409_CR3","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1056\/NEJM200004133421502","volume":"342","author":"GM Felker","year":"2000","unstructured":"Felker, G. M. et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N. Engl. J. Med. 342, 1077\u20131084 (2000).","journal-title":"N. Engl. J. Med."},{"key":"95409_CR4","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1007\/s11886-022-01727-z","volume":"24","author":"JN Njoroge","year":"2022","unstructured":"Njoroge, J. N., Mangena, J. C., Aribeana, C. & Parikh, V. N. Emerging genotype-phenotype associations in dilated cardiomyopathy. Curr. Cardiol. Rep. 24, 1077\u20131084 (2022).","journal-title":"Curr. Cardiol. Rep."},{"key":"95409_CR5","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.jacep.2017.12.003","volume":"4","author":"RL Begay","year":"2018","unstructured":"Begay, R. L. et al. Filamin C truncation mutations are associated with arrhythmogenic dilated cardiomyopathy and changes in the cell-cell adhesion structures. JACC Clin. Electrophysiol. 4, 504\u2013514 (2018).","journal-title":"JACC Clin. Electrophysiol."},{"key":"95409_CR6","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1161\/CIRCULATIONAHA.117.031947","volume":"138","author":"MMG van den Hoogenhof","year":"2018","unstructured":"van den Hoogenhof, M. M. G. et al. RBM20 mutations induce an arrhythmogenic dilated cardiomyopathy related to disturbed calcium handling. Circulation 138, 1330\u20131342 (2018).","journal-title":"Circulation"},{"key":"95409_CR7","doi-asserted-by":"crossref","first-page":"e005371","DOI":"10.1161\/CIRCHEARTFAILURE.118.005371","volume":"12","author":"VN Parikh","year":"2019","unstructured":"Parikh, V. N. et al. Regional variation in RBM20 causes a highly penetrant arrhythmogenic cardiomyopathy. Circ. Heart Fail. 12, e005371 (2019).","journal-title":"Circ. Heart Fail."},{"key":"95409_CR8","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1016\/j.jacc.2016.08.058","volume":"68","author":"S Kumar","year":"2016","unstructured":"Kumar, S. et al. Long-term arrhythmic and nonarrhythmic outcomes of lamin A\/C mutation carriers. J. Am. Coll. Cardiol. 68, 2299\u20132307 (2016).","journal-title":"J. Am. Coll. Cardiol."},{"key":"95409_CR9","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1093\/nar\/gks1362","volume":"41","author":"S Li","year":"2013","unstructured":"Li, S., Guo, W., Dewey, C. N. & Greaser, M. L. Rbm20 regulates titin alternative splicing as a splicing repressor. Nucleic Acids Res. 41, 2659\u20132672 (2013).","journal-title":"Nucleic Acids Res."},{"key":"95409_CR10","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.1172\/JCI74523","volume":"124","author":"H Maatz","year":"2014","unstructured":"Maatz, H. et al. RNA-binding protein RBM20 represses splicing to orchestrate cardiac pre-mRNA processing. J. Clin. Invest. 124, 3419\u20133430 (2014).","journal-title":"J. Clin. Invest."},{"key":"95409_CR11","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/nm.2693","volume":"18","author":"W Guo","year":"2012","unstructured":"Guo, W. et al. RBM20, a gene for hereditary cardiomyopathy, regulates titin splicing. Nat. Med. 18, 766\u2013773 (2012).","journal-title":"Nat. Med."},{"key":"95409_CR12","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.jacc.2009.05.038","volume":"54","author":"KM Brauch","year":"2009","unstructured":"Brauch, K. M. et al. Mutations in ribonucleic acid binding protein gene cause familial dilated cardiomyopathy. J. Am. Coll. Cardiol. 54, 930\u2013941 (2009).","journal-title":"J. Am. Coll. Cardiol."},{"key":"95409_CR13","doi-asserted-by":"crossref","first-page":"17894","DOI":"10.1038\/s41598-020-74800-8","volume":"10","author":"K Ihara","year":"2020","unstructured":"Ihara, K. et al. A missense mutation in the RSRSP stretch of Rbm20 causes dilated cardiomyopathy and atrial fibrillation in mice. Sci. Rep. 10, 17894 (2020).","journal-title":"Sci. Rep."},{"key":"95409_CR14","first-page":"127","volume":"106","author":"E Kayvanpour","year":"2017","unstructured":"Kayvanpour, E. et al. Genotype-phenotype associations in dilated cardiomyopathy: meta-analysis on more than 8000 individuals. Clin. Res. Cardiol. Off. J. German Cardiac Soc. 106, 127\u2013139 (2017).","journal-title":"Clin. Res. Cardiol. Off. J. German Cardiac Soc."},{"key":"95409_CR15","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1016\/j.jacc.2017.08.063","volume":"70","author":"U Tayal","year":"2017","unstructured":"Tayal, U. et al. Phenotype and clinical outcomes of titin cardiomyopathy. J. Am. Coll. Cardiol. 70, 2264\u20132274 (2017).","journal-title":"J. Am. Coll. Cardiol."},{"key":"95409_CR16","doi-asserted-by":"crossref","first-page":"e006832","DOI":"10.1161\/CIRCHEARTFAILURE.119.006832","volume":"13","author":"MM Akhtar","year":"2020","unstructured":"Akhtar, M. M. et al. Clinical phenotypes and prognosis of dilated cardiomyopathy caused by truncating variants in the TTN gene. Circ. Heart Fail. 13, e006832 (2020).","journal-title":"Circ. Heart Fail."},{"key":"95409_CR17","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1002\/ehf2.12689","volume":"7","author":"A Sammani","year":"2020","unstructured":"Sammani, A. et al. Predicting sustained ventricular arrhythmias in dilated cardiomyopathy: a meta-analysis and systematic review. ESC Heart Fail. 7, 1430\u20131441 (2020).","journal-title":"ESC Heart Fail."},{"key":"95409_CR18","first-page":"1307","volume":"24","author":"AAM Wilde","year":"2022","unstructured":"Wilde, A. A. M. et al. European heart rhythm association (EHRA)\/heart rhythm society (HRS)\/Asia pacific heart rhythm society (APHRS)\/Latin American heart rhythm society (LAHRS) expert consensus statement on the state of genetic testing for cardiac diseases. Eur. Eur. Pac. Arrhythm. Cardiac Electrophysiol. J. Work. Groups Cardiac Pac. Arrhythm. Cardiac Cell. Electrophysiol. Eur. Soc. Cardiol. 24, 1307\u20131367 (2022).","journal-title":"Eur. Eur. Pac. Arrhythm. Cardiac Electrophysiol. J. Work. Groups Cardiac Pac. Arrhythm. Cardiac Cell. Electrophysiol. Eur. Soc. Cardiol."},{"key":"95409_CR19","doi-asserted-by":"crossref","first-page":"e301","DOI":"10.1016\/j.hrthm.2019.05.007","volume":"16","author":"JA Towbin","year":"2019","unstructured":"Towbin, J. A. et al. 2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy. Heart Rhythm 16, e301\u2013e372 (2019).","journal-title":"Heart Rhythm"},{"key":"95409_CR20","doi-asserted-by":"crossref","first-page":"e004059","DOI":"10.1161\/CIRCGEN.123.004059","volume":"16","author":"DE Cannie","year":"2023","unstructured":"Cannie, D. E. et al. Risks of ventricular arrhythmia and heart failure in carriers of RBM20 variants. Circ. Genom. Precis. Med. 16, e004059 (2023).","journal-title":"Circ. Genom. Precis. Med."},{"key":"95409_CR21","doi-asserted-by":"crossref","first-page":"e002149","DOI":"10.1161\/JAHA.115.002149","volume":"4","author":"A Spezzacatene","year":"2015","unstructured":"Spezzacatene, A. et al. Arrhythmogenic phenotype in dilated cardiomyopathy: Natural history and predictors of life-threatening arrhythmias. J. Am. Heart Assoc. 4, e002149 (2015).","journal-title":"J. Am. Heart Assoc."},{"key":"95409_CR22","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1093\/cvr\/cvw192","volume":"112","author":"A Beqqali","year":"2016","unstructured":"Beqqali, A. et al. A mutation in the glutamate-rich region of RNA-binding motif protein 20 causes dilated cardiomyopathy through missplicing of titin and impaired Frank-Starling mechanism. Cardiovasc. Res. 112, 452\u2013463 (2016).","journal-title":"Cardiovasc. Res."},{"key":"95409_CR23","doi-asserted-by":"publisher","DOI":"10.1113\/JP283082","author":"KT MacLeod","year":"2022","unstructured":"MacLeod, K. T. Changes in cellular Ca(2+) and Na(+) regulation during the progression towards heart failure. J. Physiol. https:\/\/doi.org\/10.1113\/JP283082 (2022).","journal-title":"J. Physiol."},{"key":"95409_CR24","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.ade1633","author":"T Nishiyama","year":"2022","unstructured":"Nishiyama, T. et al. Precise genomic editing of pathogenic mutations in RBM20 rescues dilated cardiomyopathy. Sci. Transl. Med. https:\/\/doi.org\/10.1126\/scitranslmed.ade1633 (2022).","journal-title":"Sci. Transl. Med."},{"key":"95409_CR25","doi-asserted-by":"crossref","first-page":"e005700","DOI":"10.1161\/CIRCHEARTFAILURE.118.005700","volume":"12","author":"TM Hey","year":"2019","unstructured":"Hey, T. M. et al. Pathogenic RBM20-variants are associated with a severe disease expression in male patients with dilated cardiomyopathy. Circ. Heart Fail. 12, e005700 (2019).","journal-title":"Circ. Heart Fail."},{"key":"95409_CR26","doi-asserted-by":"crossref","first-page":"H1296","DOI":"10.1152\/ajpheart.00328.2022","volume":"323","author":"DC Lennermann","year":"2022","unstructured":"Lennermann, D. C. et al. Deep phenotyping of two preclinical mouse models and a cohort of RBM20 mutation carriers reveals no sex-dependent disease severity in RBM20 cardiomyopathy. Am. J. Physiol. Heart Circ. Physiol. 323, H1296-h1310 (2022).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"95409_CR27","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1161\/CIRCULATIONAHA.119.044934","volume":"141","author":"ED Smith","year":"2020","unstructured":"Smith, E. D. et al. Desmoplakin cardiomyopathy, a fibrotic and inflammatory form of cardiomyopathy distinct from typical dilated or arrhythmogenic right ventricular cardiomyopathy. Circulation 141, 1872\u20131884 (2020).","journal-title":"Circulation"},{"key":"95409_CR28","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1002\/ejhf.2514","volume":"24","author":"JG Mirelis","year":"2022","unstructured":"Mirelis, J. G. et al. Combination of late gadolinium enhancement and genotype improves prediction of prognosis in non-ischaemic dilated cardiomyopathy. Eur. J. Heart Fail. 24, 1183\u20131196 (2022).","journal-title":"Eur. J. Heart Fail."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-95409-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-95409-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-95409-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T20:50:07Z","timestamp":1743195007000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-95409-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,28]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["95409"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-95409-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,28]]},"assertion":[{"value":"7 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"MJA is a consultant for Abbott, Boston Scientific, Bristol Myers Squibb, Daiichi Sankyo, Invitae, Medtronic, Tenaya Therapeutics, and UpToDate. MJA and Mayo Clinic have a royalty\/equity relationship with AliveCor, Anumana, ARMGO Pharma, Pfizer, and Thryv Therapeutics. JRG is a consultant for Avidity Biosciences and serves as the principal investigator for clinical trials sponsored by Tenaya Therapeutics. However, none of these entities have contributed to this study in any manner. RG, MC, RN, NLP, CM, and JWS have no conflicts to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10716"}}